KMT2A and cancer: Recurrent mutations in MLL geneshave been identified in several other cancers, including lung squamous cellcarcinoma, and been associated with poor clinical outcomes (Morin et al., 2011; Grasso et al., 2012; Jones et al., 2012; Kim et al., 2014; Seiwert et al., 2015).